Form 4: Neuraxis Director Bradley Mitchell Watkins Acquires 11,580 Shares of Common Stock

Director Bradley Mitchell Watkins acquired 11,580 shares of Neuraxis, Inc. common stock on June 28, 2024, as compensation for services.

Summary

• On June 28, 2024, Bradley Mitchell Watkins, a director of Neuraxis, Inc., acquired 11,580 shares of common stock.
• The acquisition was made pursuant to an Unrestricted Stock Award Agreement.
• These shares were issued as compensation for services provided as a member of the Board of Directors through March 31, 2024.
• The number of shares was determined by dividing $32,191.78 by the closing price of the common stock on June 28, 2024, which was $2.78 per share.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction (stock award for director compensation), indicating stability and alignment of interests. It's a neutral positive.

Positives

• The acquisition of shares by a director demonstrates confidence in the company.

Industry Context

This type of stock award is a common practice for compensating board members in publicly traded companies, aligning their interests with those of the shareholders.

Comparison to Industry Standards

• Stock awards to directors are a standard form of compensation in the biotech and medical device industries, often used by companies like Medtronic or Boston Scientific.
• The value of the award is relatively small, suggesting it is a standard retainer for board service rather than a performance-based bonus.

Stakeholder Impact

• The stock award aligns the director's interests with those of the shareholders.

Key Dates